Viewing Study NCT02017457

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2026-02-03 @ 1:39 PM
Study NCT ID: NCT02017457
Status: COMPLETED
Last Update Posted: 2019-12-10
First Post: 2013-12-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.
Sponsor: Carlos Graux, MD, PhD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myelogenous Leukemia View
None Myelodysplastic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hematology View
None Acute Myelogenous Leukemia View
None Myelodysplasic syndrome View
None Allogeneic stem cell transplantation View
None Donor lymphocyte infusion View
None DLI View
None Azacytidine View
None Vidaza View
None Overall response rate View
None Relapse View